{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomized to laser versus radiofrequency ablation (RFA)."
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients diagnosed by percutaneous biopsy (ultrasound or stereotactic-guided) with breast cancer \u22641.5cm, >1cm from the skin and <5mm residual disease by MRI were accrued to this IRB-approved study."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomized to laser versus radiofrequency ablation (RFA)."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objectives: Percutaneous ablation of breast cancer has shown promise as a treatment alternative to open lumpectomy."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients were randomized to laser versus radiofrequency ablation (RFA)."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "21 patients were accrued to the study."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Fifteen patients received RFA and all showed 100% ablation and negative margins."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  },
  "model": "gpt-4o"
}